Current strategies for brain drug delivery

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

The blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The BBB in healthy brain is a diffusion barrier essential for protecting normal brain function by impeding most compounds from transiting from the blood to the brain; only small molecules can cross the BBB. Under certain pathological conditions of diseases such as stroke, diabetes, seizures, multiple sclerosis, Parkinson's disease and Alzheimer disease, the BBB is disrupted. The objective of this review is to provide a broad overview on current strategies for brain drug delivery and related subjects from the past five years. It is hoped that this review could inspire readers to discover possible approaches to deliver drugs into the brain. After an initial overview of the BBB structure and function in both healthy and pathological conditions, this review re-visits, according to recent publications, some questions that are controversial, such as whether nanoparticles by themselves could cross the BBB and whether drugs are specifically transferred to the brain by actively targeted nanoparticles. Current non-nanoparticle strategies are also reviewed, such as delivery of drugs through the permeable BBB under pathological conditions and using non-invasive techniques to enhance brain drug uptake. Finally, one particular area that is often neglected in brain drug delivery is the influence of aging on the BBB, which is captured in this review based on the limited studies in the literature.

Original languageEnglish
Pages (from-to)1481-1493
Number of pages13
JournalTheranostics
Volume8
Issue number6
DOIs
StatePublished - 1 Jan 2018

Fingerprint

Blood-Brain Barrier
Brain
Pharmaceutical Preparations
Nanoparticles
Multiple Sclerosis
Parkinson Disease
Alzheimer Disease
Seizures
Stroke

Keywords

  • Actively targeted delivery
  • Aging
  • Disease conditions
  • Permeable blood-brain barrier

Cite this

Dong, Xiaowei. / Current strategies for brain drug delivery. In: Theranostics. 2018 ; Vol. 8, No. 6. pp. 1481-1493.
@article{43326ce7e2444bf7a61e56a83b9eed8d,
title = "Current strategies for brain drug delivery",
abstract = "The blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The BBB in healthy brain is a diffusion barrier essential for protecting normal brain function by impeding most compounds from transiting from the blood to the brain; only small molecules can cross the BBB. Under certain pathological conditions of diseases such as stroke, diabetes, seizures, multiple sclerosis, Parkinson's disease and Alzheimer disease, the BBB is disrupted. The objective of this review is to provide a broad overview on current strategies for brain drug delivery and related subjects from the past five years. It is hoped that this review could inspire readers to discover possible approaches to deliver drugs into the brain. After an initial overview of the BBB structure and function in both healthy and pathological conditions, this review re-visits, according to recent publications, some questions that are controversial, such as whether nanoparticles by themselves could cross the BBB and whether drugs are specifically transferred to the brain by actively targeted nanoparticles. Current non-nanoparticle strategies are also reviewed, such as delivery of drugs through the permeable BBB under pathological conditions and using non-invasive techniques to enhance brain drug uptake. Finally, one particular area that is often neglected in brain drug delivery is the influence of aging on the BBB, which is captured in this review based on the limited studies in the literature.",
keywords = "Actively targeted delivery, Aging, Disease conditions, Permeable blood-brain barrier",
author = "Xiaowei Dong",
year = "2018",
month = "1",
day = "1",
doi = "10.7150/thno.21254",
language = "English",
volume = "8",
pages = "1481--1493",
journal = "Theranostics",
issn = "1838-7640",
publisher = "Ivyspring International Publisher",
number = "6",

}

Current strategies for brain drug delivery. / Dong, Xiaowei.

In: Theranostics, Vol. 8, No. 6, 01.01.2018, p. 1481-1493.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Current strategies for brain drug delivery

AU - Dong, Xiaowei

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The BBB in healthy brain is a diffusion barrier essential for protecting normal brain function by impeding most compounds from transiting from the blood to the brain; only small molecules can cross the BBB. Under certain pathological conditions of diseases such as stroke, diabetes, seizures, multiple sclerosis, Parkinson's disease and Alzheimer disease, the BBB is disrupted. The objective of this review is to provide a broad overview on current strategies for brain drug delivery and related subjects from the past five years. It is hoped that this review could inspire readers to discover possible approaches to deliver drugs into the brain. After an initial overview of the BBB structure and function in both healthy and pathological conditions, this review re-visits, according to recent publications, some questions that are controversial, such as whether nanoparticles by themselves could cross the BBB and whether drugs are specifically transferred to the brain by actively targeted nanoparticles. Current non-nanoparticle strategies are also reviewed, such as delivery of drugs through the permeable BBB under pathological conditions and using non-invasive techniques to enhance brain drug uptake. Finally, one particular area that is often neglected in brain drug delivery is the influence of aging on the BBB, which is captured in this review based on the limited studies in the literature.

AB - The blood-brain barrier (BBB) has been a great hurdle for brain drug delivery. The BBB in healthy brain is a diffusion barrier essential for protecting normal brain function by impeding most compounds from transiting from the blood to the brain; only small molecules can cross the BBB. Under certain pathological conditions of diseases such as stroke, diabetes, seizures, multiple sclerosis, Parkinson's disease and Alzheimer disease, the BBB is disrupted. The objective of this review is to provide a broad overview on current strategies for brain drug delivery and related subjects from the past five years. It is hoped that this review could inspire readers to discover possible approaches to deliver drugs into the brain. After an initial overview of the BBB structure and function in both healthy and pathological conditions, this review re-visits, according to recent publications, some questions that are controversial, such as whether nanoparticles by themselves could cross the BBB and whether drugs are specifically transferred to the brain by actively targeted nanoparticles. Current non-nanoparticle strategies are also reviewed, such as delivery of drugs through the permeable BBB under pathological conditions and using non-invasive techniques to enhance brain drug uptake. Finally, one particular area that is often neglected in brain drug delivery is the influence of aging on the BBB, which is captured in this review based on the limited studies in the literature.

KW - Actively targeted delivery

KW - Aging

KW - Disease conditions

KW - Permeable blood-brain barrier

UR - http://www.scopus.com/inward/record.url?scp=85041585054&partnerID=8YFLogxK

U2 - 10.7150/thno.21254

DO - 10.7150/thno.21254

M3 - Review article

C2 - 29556336

AN - SCOPUS:85041585054

VL - 8

SP - 1481

EP - 1493

JO - Theranostics

JF - Theranostics

SN - 1838-7640

IS - 6

ER -